MSB 7.69% $1.19 mesoblast limited

Ann: FDA Grants Orphan Drug Designation for Revascor, page-53

  1. 1,098 Posts.
    lightbulb Created with Sketch. 169
    Hey @Lopez, isn't it it end of month, SI did say end of Feb for the meeting. Oh ok, you are taking into account the official response from the FDA.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.